Porvair Filtration Group, a leading innovator in the fields of filtration and separation, has developed a new technology that has particular relevance to the rapidly expanding Epigenetics market and will be unveiling it at the Epigenetics World Congress in Boston in April 2011.

Chromatin Immunoprecipitation (ChIP) is the key experimental technique used to investigate the interaction between proteins and DNA in the cell. It aims to determine whether specific proteins are associated with specific genomic regions. ChIP is a core enabling technique that is being widely adopted in the rapidly growing field of Epigenetics.

Using a new approach, based on a rigid porous polymer matrix rather than the traditional sepharose or magnetic beads, Porvair has developed a novel Chromatin ImmunoPrecipitation (ChIP) assay kit called Chromatrap^TM.

Results from third party field trials, to be presented at the Epigenetics World Congress, demonstrate that Chromatrap^TM is able to routinely deliver greater ChIP specificity, higher ChIP sensitivity and faster separations than traditional sepharose or magnetic bead approaches.

For further information or to discuss evaluating the new Chromatrap^TM ChIP assay technique please contact Porvair Filtration Group on +44-1489-864330 / Kevin.Quinlan@porvairfiltration.com or visit Stand 10 at the Epigenetics World Congress.

Porvair Filtration Group is an international leader in the development and supply of materials and products for applications in filtration and separation. Their expertise in a wide range of media and the dedication of their design, manufacturing, sales, test and research teams ensure they are at the forefront of filtration technology, delivering world class performance to the Aerospace, Defence, Nuclear, Energy, Chemical Process, Industrial Process, Water Treatment, Printing and Life Science markets. With offices and manufacturing sites located in the UK, Europe and the USA combined with a world-wide network of market representatives and distributors, they pride themselves on their continuous innovation and research to meet global demands.